Tissue/ cell preparation: Infectious Laryngotracheitis virus.
Our Abpromise guarantee covers the use of ab30491 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent dilution.|
|Neutralising||Use at an assay dependent dilution.|
ab30491 has not yet been referenced specifically in any publications.